On the other hand, patient education level, place of residence, axillary node status, estrogen receptor, tumor size, body mass index at diagnosis, stage of cancer, baseline treatment, histologic grade, number of positive lymph nodes involved, and type of hormone used had a negative association with the survival of breast cancer. This evidence concerns the gene ESR1 and breast cancer.